FRX

Fennec Pharms

• Dow Jones·05/22 11:00

  Fennec Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

• Dow Jones·05/22 11:00

  Fennec Pharmaceuticals Price Target Raised to $16.00/Share From $13.00 by HC Wainwright & Co.

• Dow Jones·05/14 10:30

  *Fennec Pharmaceuticals 1Q Rev $15.1M >FRX.T

• Dow Jones·05/14 10:30

  *Fennec Pharmaceuticals 1Q EPS 1c >FRX.T

• Dow Jones·04/16 13:39

  Fennec Pharmaceuticals Price Target Maintained With a $13.00/Share by Wedbush

• Dow Jones·03/24 14:33

  Fennec Pharmaceuticals Stock Falls on Widened 4Q Loss

• Dow Jones·03/24 11:05

  *Fennec Pharmaceuticals 4Q Rev $13.8M >FRX.T

• Dow Jones·03/24 11:03

  *Fennec Pharmaceuticals 4Q Loss/Shr 17c >FRX.T

• Dow Jones·01/09 13:32

  Fennec Pharmaceuticals Price Target Announced at $18.00/Share by Piper Sandler

• Dow Jones·11/14/2025 04:23

  *Fennec Pharmaceuticals to Offer Shares at $7.50 Each to Some Institutional Shareholders >FRX.T

• Dow Jones·11/14/2025 04:17

  *Fennec Pharmaceuticals Announces Private Offering of Common Shares in Canada

• Dow Jones·11/14/2025 04:14

  *Fennec Pharmaceuticals to Use Remaining Proceeds, if Any, for Working Capital, General Purposes >FRX.T

• Dow Jones·11/14/2025 04:14

  *Fennec Pharmaceuticals Plans to Use Net Proceeds of Offering to Repurchase and Redeem Some Debt >FRX.T

• Dow Jones·11/14/2025 04:13

  *Fennec Pharmaceuticals Grants Underwriters Option to Buy Additional 700,000 Shares >FRX.T

• Dow Jones·11/14/2025 04:13

  *Fennec Pharmaceuticals Expects $35.0M in Gross Proceeds From Offering >FRX.T